Les Sulewski

Stock Analyst at Truist Securities

(0.41)

# 4,407

Out of 4,415 analysts

2

Total ratings

50%

Success rate

-15.17%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	COLL Collegium Pharmaceutical	Maintains: Buy	$37 → $40	$37.51	+6.64%	1	Feb 26, 2024
	PCRX Pacira BioSciences	Maintains: Buy	$60 → $55	$27.32	+101.32%	1	Aug 3, 2023

Collegium Pharmaceutical

Feb 26, 2024

Maintains: Buy

Price Target: $37 → $40

Current: $37.51

Upside: +6.64%

Pacira BioSciences

Aug 3, 2023

Maintains: Buy

Price Target: $60 → $55

Current: $27.32

Upside: +101.32%